3M Avagard - Solventum US LLC | Grain Processing Corporation

Manufacturer: Solventum US LLC | Grain Processing Corporation
Effective date: 2026-04-22
Label type: HUMAN OTC DRUG LABEL
Version: 19
Source: full-release
Hydrated at: 2026-06-01 01:54:44

Label at a glance#

Product3M Avagard

Active ingredientChlorhexidine Gluconate, Alcohol

Label structure10 sections

Indications and uses

surgical hand antiseptic: significantly reduces the number of micro-organisms on the hands and forearms prior to surgery or patient care healthcare personnel hand antiseptic: hand rub to help reduce bacteria that potentially can cause disease recommended for repeated use

Dosage and administration

use with care in premature infants or infants under 2 months of age. These products may cause irritation or chemical burns. Surgical hand antiseptic apply to clean, dry hands and nails. For the first use of each day, clean under nails with a nail stick. dispense one pump (2 mL) into the palm of one hand dip the fingertips of the opposite hand into the lotion and work it under the nails spread the remaining lotion ...

Contacts and useful links#

PhoneLabel contact1-800-228-3957

Websitewww.3m.com

www.3M.com/infectionprevention

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Chlorhexidine gluconate 1% w/w

Ethyl alcohol 61% w/w

Purpose

OTC - PURPOSE SECTION

Antiseptic

Uses

INDICATIONS & USAGE SECTION

surgical hand antiseptic: significantly reduces the number of micro-organisms on the hands and forearms prior to surgery or patient care
healthcare personnel hand antiseptic: hand rub to help reduce bacteria that potentially can cause disease
recommended for repeated use

Warnings

WARNINGS SECTION

For external use only. Flammable, keep away from fire or flames.

Allergy alert: This product may cause a severe allergic reaction. Symptoms may include:

wheezing/difficulty breathing
shock
facial swelling
hives
rash

If an allergic reaction occurs, stop use and seek medical help right away.

OTC - DO NOT USE SECTION

Do not use if you are allergic to chlorhexidine gluconate or any other ingredient in this product

When using this product

OTC - WHEN USING SECTION

do not touch the eye with hands that have been treated with this preparation
keep out of eyes, ears, and mouth. May cause serious and permanent eye injury if permitted to enter and remain in the eye.
if contact occurs, rinse with cold water right away
do not use routinely if you have wounds which involve more than the superficial layers of the skin

OTC - STOP USE SECTION

Stop use and ask a doctor if irritation, sensitization, or allergic reaction occurs. These may be signs of a serious condition

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

use with care in premature infants or infants under 2 months of age. These products may cause irritation or chemical burns.

Surgical hand antiseptic

apply to clean, dry hands and nails. For the first use of each day, clean under nails with a nail stick.
dispense one pump (2 mL) into the palm of one hand
dip the fingertips of the opposite hand into the lotion and work it under the nails
spread the remaining lotion over the hand and up to just above the elbow
using another 2 mL of lotion, repeat with the other hand
dispense another 2 mL of lotion into either hand; reapply to all aspects of both hands up to the wrists
allow to dry before donning gloves

Healthcare personnel hand antiseptic

apply to clean, dry hands and nails
dispense one pump (2 mL) into the palm of one hand
paying particular attention to the spaces between the fingers and under fingernails, apply the lotion evenly to cover both hands up to the wrists
allow to dry without wiping

Other information

OTHER SAFETY INFORMATION

store at 20-25°C (68-77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

beheneth 10, behenyl alcohol, C20-40 pareth-24, cetyl palmitate, diisopropyl dimer dilinoleate, dimethicone, glycerin, polyethylene glycol, squalane, water

Questions?

OTC - QUESTIONS SECTION

Call 1-800-228-3957

Principle Display Panel – 500mL Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 17518-051-01

Avagard™

(Chlorhexidine Gluconate 1% Solution and Ethyl Alcohol 61% w/w)

Surgical and Healthcare Personnel Hand Antiseptic with Moisturizers

Peel to read Drug Facts Panel before use

Made in U.S.A. for 3M Health Care

2510 Conway Ave., St. Paul, MN 55144

1-800-228-3957

www.3M.com/infectionprevention

Patent: 3M.com/Patents

MAL10110039XC

Flammable, keep away from fire or flame, heat, sparks and sources of static discharge.

LOT 0000000000

EXP 0000-00-00

16 fl oz • 500 mL

REF 9200

Principle Display Panel – 500mL Bottle Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1090000	avagard (chlorhexidine gluconate 1 % / ethanol 61 % ) Topical Lotion	PSN	19
1089996	chlorhexidine gluconate 1 % / ethanol 61 % Topical Lotion	PSN	19
1090000	chlorhexidine gluconate 10 MG/ML / ethanol 0.61 ML/ML Topical Lotion [Avagard]	SBD	19
1089996	chlorhexidine gluconate 10 MG/ML / ethanol 0.61 ML/ML Topical Lotion	SCD	19
1090000	avagard (chlorhexidine gluconate 1 % / ethanol 61 % ) Topical Lotion	SY	19

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
CHLORHEXIDINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
6c13b22c-b3ba-4127-b768-0132dd5ab0d1	Product name	1	20230829
bb6d6c68-649d-4e6d-a1f6-603d969c8f68	Product name	1	20160303

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
17518-051-01	3M Avagard	8 in 1 CASE	LOTION	8	19
17518-051-01	3M Avagard	500 mL in 1 BOTTLE	LOTION	500	19
17518-051-04	3M Avagard	4 in 1 CASE	LOTION	4	19
17518-051-04	3M Avagard	1200 mL in 1 BOTTLE	LOTION	1200	19

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
17518-051-01	ML - Milliliter	17518-051	757a4fb8-a521-4953-8559-11342fb57c1e	1	2022-06-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Alcohol	ACTIVE INGREDIENT	3K9958V90M	4
Chlorhexidine Gluconate	ACTIVE INGREDIENT	MOR84MUD8E	4
Alcohol	ACTIVE MOIETY	3K9958V90M	4
Chlorhexidine	ACTIVE MOIETY	R4KO0DY52L	4
beheneth-10	INACTIVE INGREDIENT	313S43DM16	4
cetyl palmitate	INACTIVE INGREDIENT	5ZA2S6B08X	4
dimethicone	INACTIVE INGREDIENT	92RU3N3Y1O	4
docosanol	INACTIVE INGREDIENT	9G1OE216XY	4
glycerin	INACTIVE INGREDIENT	PDC6A3C0OX	4
polyethylene glycols	INACTIVE INGREDIENT	3WJQ0SDW1A	4
squalane	INACTIVE INGREDIENT	GW89575KF9	4
water	INACTIVE INGREDIENT	059QF0KO0R	4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

3M Avagard
Chlorhexidine Gluconate and Alcohol
Chlorhexidine Gluconate
Chlorhexidine
Alcohol
Beheneth-10
Docosanol
Cetyl Palmitate
Dimethicone
Glycerin
polyethylene glycol, unspecified
Squalane
Water

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
17518-051	17518-051-01, 17518-051-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Chlorhexidine Gluconate	MOR84MUD8E	ACTIB
Alcohol	3K9958V90M	ACTIB
Beheneth-10	313S43DM16	IACT
Docosanol	9G1OE216XY	IACT
Cetyl Palmitate	5ZA2S6B08X	IACT
Dimethicone	92RU3N3Y1O	IACT
Glycerin	PDC6A3C0OX	IACT
polyethylene glycol, unspecified	3WJQ0SDW1A	IACT
Squalane	GW89575KF9	IACT
Water	059QF0KO0R	IACT

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 30 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
docosanol	DOCOSANOL	9G1OE216XY	SOLUTION / TOPICAL	1.1 %w/w		Exact identifier — unii+route 6 equally ranked IID candidates
cetyl palmitate	CETYL PALMITATE	5ZA2S6B08X	SOLUTION / TOPICAL	0.05 %w/w		Exact identifier — unii+route 9 equally ranked IID candidates
cetyl palmitate	CETYL PALMITATE	5ZA2S6B08X	CREAM / TOPICAL	0.32 %w/w		Exact identifier — unii+route 9 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	LOTION / TOPICAL		3990 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
squalane	SQUALANE	GW89575KF9	SOLUTION / TOPICAL	1 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
cetyl palmitate	CETYL PALMITATE	5ZA2S6B08X	CREAM / TOPICAL	0.32 %w/w		Exact identifier — unii+route 9 equally ranked IID candidates
squalane	SQUALANE	GW89575KF9	SOLUTION / TOPICAL	1 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
squalane	SQUALANE	GW89575KF9	CREAM / TOPICAL	6 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
docosanol	DOCOSANOL	9G1OE216XY	AEROSOL, FOAM / TOPICAL	1.1 %w/w		Exact identifier — unii+route 6 equally ranked IID candidates
squalane	SQUALANE	GW89575KF9	CREAM, AUGMENTED / TOPICAL		120 mg	Exact identifier — unii+route 12 equally ranked IID candidates
cetyl palmitate	CETYL PALMITATE	5ZA2S6B08X	SOLUTION / TOPICAL	0.05 %w/w		Exact identifier — unii+route 9 equally ranked IID candidates
docosanol	DOCOSANOL	9G1OE216XY	SOLUTION / TOPICAL	1.1 %w/w		Exact identifier — unii+route 6 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	LOTION / TOPICAL		3990 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
squalane	SQUALANE	GW89575KF9	AEROSOL, FOAM / TOPICAL	2.23 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
cetyl palmitate	CETYL PALMITATE	5ZA2S6B08X	OINTMENT / TOPICAL	NA		Exact identifier — unii+route 9 equally ranked IID candidates
cetyl palmitate	CETYL PALMITATE	5ZA2S6B08X	SOLUTION / TOPICAL	0.05 %w/w		Exact identifier — unii+route 9 equally ranked IID candidates
docosanol	DOCOSANOL	9G1OE216XY	AEROSOL, FOAM / TOPICAL	1.1 %w/w		Exact identifier — unii+route 6 equally ranked IID candidates
cetyl palmitate	CETYL PALMITATE	5ZA2S6B08X	OINTMENT / TOPICAL	NA		Exact identifier — unii+route 9 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	LOTION / TOPICAL		3990 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
docosanol	DOCOSANOL	9G1OE216XY	AEROSOL, FOAM / TOPICAL	1.1 %w/w		Exact identifier — unii+route 6 equally ranked IID candidates
squalane	SQUALANE	GW89575KF9	CREAM, AUGMENTED / TOPICAL		120 mg	Exact identifier — unii+route 12 equally ranked IID candidates
squalane	SQUALANE	GW89575KF9	SOLUTION / TOPICAL	1 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
squalane	SQUALANE	GW89575KF9	CREAM / TOPICAL	6 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
squalane	SQUALANE	GW89575KF9	AEROSOL, FOAM / TOPICAL	2.23 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
squalane	SQUALANE	GW89575KF9	CREAM, AUGMENTED / TOPICAL		120 mg	Exact identifier — unii+route 12 equally ranked IID candidates
squalane	SQUALANE	GW89575KF9	AEROSOL, FOAM / TOPICAL	2.23 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
docosanol	DOCOSANOL	9G1OE216XY	SOLUTION / TOPICAL	1.1 %w/w		Exact identifier — unii+route 6 equally ranked IID candidates
squalane	SQUALANE	GW89575KF9	CREAM / TOPICAL	6 %w/w		Exact identifier — unii+route 12 equally ranked IID candidates
cetyl palmitate	CETYL PALMITATE	5ZA2S6B08X	CREAM / TOPICAL	0.32 %w/w		Exact identifier — unii+route 9 equally ranked IID candidates
cetyl palmitate	CETYL PALMITATE	5ZA2S6B08X	OINTMENT / TOPICAL	NA		Exact identifier — unii+route 9 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021074-001	AVAGARD	ALCOHOL; CHLORHEXIDINE GLUCONATE	61%;1%	SOLUTION / TOPICAL		RLD, RS	2001-06-07

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021074-001	AVAGARD	61%;1%	SOLUTION / TOPICAL	RLD, RS	2001-06-07	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
3M Avagard	CHLORHEXIDINE GLUCONATE AND ALCOHOL	Solventum US LLC	8bf8fe8e-76cb-4eda-a18d-1687050285ae	2026-04-22	Warnings	Exact identifier ndc (package): 17518-051-04 ndc (package): 17518-051-01 ndc (product): 17518-051 ndc11 (package): 17518005104 ndc11 (package): 17518005101 spl id: a62bdc56-7a01-4c95-ab20-6098ade5a0b2 spl set id: 8bf8fe8e-76cb-4eda-a18d-1687050285ae

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.